Two novel nanoscale preparations of micelle and thermosensitive hydrogel for docetaxel to treat malignant tumor

Journal of Biomedical Nanotechnology

Volumn 9, Issue 3, 2013, Pages 357-366

  Wang, Cheng ^a   Long, Chaofeng ^b   Xie, Chengshi ^b   Chen, Xiaoxin ^b   Zhang, Lan ^b   Chu, Bingyang ^a   Wang, Yujun ^a   Luo, Feng ^a   Qian, Zhiyong ^a  

^a SICHUAN UNIVERSITY   (China)

^b Guangdong Zhongsheng Pharmacy   (China)

Author keywords

Docetaxel; Hydrogel; Micelle; Nanoscale Preparation; PCEC

Indexed keywords

ANTI-TUMOR ACTIVITIES; COMBINATION THERAPY; DOCETAXEL; HISTOLOGICAL SECTION; NANO SCALE; PCEC; POLYDISPERSITY INDICES; THERMO-SENSITIVE HYDROGEL;

COPOLYMERS; HYDROGELS; MICELLES; NANOTECHNOLOGY; POLYETHYLENE GLYCOLS; SOLS; TUMORS;

DRUG PRODUCTS;

DOCETAXEL; EOSIN; HEMATOXYLIN; MACROGOL; POLYCAPROLACTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; BREAST CANCER; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; FEMALE; FREEZE DRYING; HEAT SENSITIVITY; HEMOLYSIS; HYDROGEL; IN VITRO STUDY; MICELLE; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHASE TRANSITION; TISSUE SECTION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VOLUME; WEIGHT; X RAY DIFFRACTION; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CELL DEATH; CELL SURVIVAL; FEMALE; HEMOLYSIS; HYDROGEL; MICE; MICE, INBRED BALB C; MICELLES; NANOTECHNOLOGY; NEOPLASMS; POLYESTERS; POLYETHYLENE GLYCOLS; RABBITS; SURVIVAL ANALYSIS; TAXOIDS; TEMPERATURE;

EID: 84876583534     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1440     Document Type: Article

References (47)

1. J. M. Brown and A. J. Giaccia, The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res. 58, 1408 (1998).
2. R. K. Jain, Barriers to drug delivery in solid tumors. Sci. Am. 271, 58 (1994).
3. V. Frenkel, Ultrasound mediated delivery of drugs and genes to solid tumors. Adv. Drug Deliv. Rev. 60, 1193 (2008).
4. R. B. Weiss, R. C. Donehower, P. H. Wiernik, T. Ohnuma, R. J. Gralla, D. L. Trump, J. R. B. Jr., D. A. V. Echo, D. D. V. Hoff, and B. L. Jones, Hypersensitivity reactions from taxol. J. Clin. Oncol. 8, 1263 (1990).
5. H. J. Guchelaar, C. H. N. ten, E. G. V, de, and N. H. Mulder, Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug taxol: A review. Clin. Oncol. 6, 40 (1994).
6. K. J. M. Schimmel, D. J. Richel, R. B. A. van den Brink, and H. J. Guchelaar, Cardiotoxicity of cytotoxic drugs. Cancer Treat. Rev. 30, 181 (2004).
7. G. F. Ismael, D. D. Rosa, M. S. Mano, and A. Awada, Novel cytotoxic drugs: Old challenges, new solutions. Cancer Treat. Rev. 34, 81 (2008).
8. T. Sridhar and R. P. Symonds, Principles of chemotherapy and radiotherapy. Obstet. Gyn. Reprod. Med. 19, 61 (2009).
9. M. Aapro and R. Bruno, Early clinical studies with docetaxel. Eur. J. Cancer 31A, S7 (1995).
10. M. C. Bissery, Preclinical pharmacology of docetaxel. Eur. J. Cancer. 31A, S1 (1995).
11. S. B. Kaye, M. Piccart, M. Aapro, P. Francis, and J. Kavanagh, Phase II trials of docetaxel (Taxotere®- in advanced ovarian cancer- an updated overview. Eur. J. Cancer 33, 2167 (1997).
12. M. Ceruti, V. Tagini, V. Recalenda, S. Arpicco, L. Cattel, M. Airoldi, and C. Bumma, Docetaxel in combination with epirubicin in metastatic breast cancer: Pharmacokinetic interactions. Farmaco. 54, 733 (1999).
13. J. Baker, J. Ajani, F. Scott, D. Winther, M. Martin, M. S. Aapro, and G. von Minckwitz, Docetaxel-related side effects and their management. Eur. J. Oncol. Nurs. 13, 49 (2009).
14. J. Fu, D. X. Wang, T. Wang, W. J Yang, Y. Deng, H. Wang, S. G. Jin, and N. Y. He, High entrapment efficiency of chitosan/polylactic acid/ tripolyphotspate nanosized microcapsules for rapamycin by an emulsion-evaporation approach. J. Biomed. Nanotechnol. 6, 725 (2010).
15. R. Goyal, S. K. Tripathi, S. Tyagi, K. R. Ram, K. M. Ansari, P. Kumar, Y. Shukla, D. K. Chowdhuri, and K. C. Gupta, Gellan gum-PEI nanocomposites as efficient gene delivery Agents. J. Biomed. Nanotechnol. 7, 38 (2011).
16. W. J. Yang, J. Fu, T. Wang, and N. Y. He, Chitosan/sodium tripolyphosphate nanoparticles: Preparation, characterization and application as drug carrier. J. Biomed. Nanotechnol. 5, 591 (2009).
17. Y. Deng, Y. Q. Zhang, H. M. Jiang, L. J. Xu, H. N. Liu, S. Li, and N. Y. He, Improvement on synthesis of different alkyl-phenylboronic acid. J. Biomed. Nanotechnol. 5, 551 (2009).
18. N. Y. He, T. Wang, L. Jiang, D. X. Wang, Y. Hu, and L. Zhang, Therapy for cerebral ischemic injury with erythropoietin-containing nanopariticles. J. Nanosci. Nanotechnol. 10, 5320 (2010).
19. Y. Deng, L. J. Xu, X. Zeng, Z. Y. Li, B. B. Qin, and N. Y. He, New perspective of GABA as an inhibitor of formation of advanced lipoxidation end-products: It's interaction with malondiadehyde. J. Biomed. Nanotechnol. 6, 318 (2010).
20. T. Wang, Z. Q. Feng, N. Y. He, Z. F. Wang, S. Li, Y. F. Guo, and L. J. Xu, A novel preparation of nanocapsules from alginateoligochitosan. J. Nanosci. Nanotechnol. 7, 4571 (2007).
21. Y. Deng, N. Y. He, X. L. Li, L. J. Xu, S. L, Z. Y. Li, and H. N. Liu, A rapid scavenger of the lipid peroxidation product malondialdehyde: New perspective of taurine. Adv. Sci. Lett. 4, 442 (2011).
22. T. Wang, Y. Hu, M. K. Leach, L. Zhang, W. J. Yang, L. Jiang, Z. Q. Feng, and N. Y. He, Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia. Int. J. Pharm. 422, 462 (2012).
23. C. Wang, Y. J. Wang, Y. J. Wang, M. Fan, F. Luo, and Z. Y. Qian, Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel. Int. J. Pharm. 414, 251 (2011).
24. S. Rai, R. Paliwal, and S. P. Vyas, Doxorubicin encapsulated nanocarriers for targeted delivery to estrogen responsive breast cancer. J. Biomed. Nanotechnol. 7, 121 (2011).
25. N. Mahajan, D. Sakarkar, A. Manmode, V. Pathak, R. Ingole, and D. Dewade, Biodegradable nanoparticles for targeted delivery in treatment of ulcerative colitis. Adv. Sci. Lett. 4, 349 (2011).
26. D. D. Ankola, R. M. Wadsworth, and M. N. K. Ravi, Nanoparticulate delivery can improve peroral bioavailability of cyclosporine and match neoral Cmax sparing the kidney from damage. J. Biomed. Nanotechnol. 7, 300 (2011).
27. A. Shahiwala and D. Dash, Preparation and evaluation of microemulsion based formulations for rapid-onset intranasal delivery of zonisamide. Adv. Sci. Lett. 3, 442 (2010).
28. A. O. Hassan and A. H. Elshafeey, Nanosized particulate systems for dermal and transdermal delivery. J. Biomed. Nanotechnol. 6, 621 (2010).
29. P. Soman, W. D. Zhang, A. Umeda, Z. W. J. Zhang, and S. C. Chen, Femtosecond laser-assisted optoporation for drug and gene delivery into single mammalian cells. J. Biomed. Nanotechnol. 7, 334 (2011).
30. G. Kwon, S. Suwa, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka, Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J. Control. Release 29, 17 (1994).
31. T. Wang and N. Y. He, Low molecular weight alginateoligochitosan nanocapsules: Preparation, characterization and applications. Nanoscale 2010, 230 (2012).
32. M. L. Gou, X. Y. Li, M. Dai, C. Y. Gong, X. H. Wang, Y. Xie, H. Deng, L. J Chen, X. Zhao, Z. Y. Qian, and Y. Q. Wei, A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel. Int. J. Pharm. 359, 228 (2008).
33. C. B. Liu, C. Y. Gong, M. J. Huang, J. W. Wang, Y. F Pan, Y. D. Zhang, G. Z. Li, M. L.Gou, K. Wang, M. J. Tu, Y. Q. Wei, and Z. Y. Qian, Thermoreversible gel-sol behavior of biodegradable PCL-PEG-PCL triblock copolymer in aqueous solutions. J. Biomed. Mater. Res. B. Appl. Biomater. 84, 165 (2008).
34. K. R. Kamath and K. Park, Biodegradable hydrogels in drug delivery. Adv. Drug Deliv. Rev. 11, 59 (1993).
35. I. Y. Galaev and B. Mattiasson, 'Smart' polymers and what they could do in biotechnology and medicine. Trends Biotechnol. 17, 335 (1999).
36. T. Kissel, Y. Li, and F. Unger, ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins. Adv. Drug Deliv. Rev. 54, 99 (2002).
37. G. E. Ruel and J. C. Leroux, In situ-forming hydrogels-review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 58, 409 (2004).
38. B. K. Nanjawade, F. V. Manvi, and A. S. Manjappa, In situ-forming hydrogels for sustained ophthalmic drug delivery. J. Control. Release 122, 119 (2007).
39. C. T. Mauro, B. F. Sonia, F. M. Leila, H. M. J. Antônio, and J. C. Paula, Preparation and characterization of a polymeric blend of PVP/PVAL for use in drug delivery system. J. Biomed. Nanotechnol. 7, 446 (2011).
40. G. Perale, F. Rossi, M. Santoro, P. Marchetti, A. Mele, F. Castiglione, E. Raffa, and M. Masi, Drug release from hydrogel: A new understanding of transport phenomena. J. Biomed. Nanotechnol. 7, 476 (2011).
41. E. Fournier, M. H. Dufresne, D. C. Smith, M. Ranger, and J. C. Leroux, A novel one-step drug loading procedure for water-soluble amphiphilic nanocarriers. Pharm. Res. 21, 962 (2004).
42. D. G. Le, S. Gori, L. Luo, D. Lessard, D. C. Smith, M. A. Yessine, M. Ranger, and J. C. Leroux, Poly(N-vinylpyrrolidone)-blockpoly (D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: In vitro and in vivo evaluation. J. Control. Release 99, 83 (2004).
43. C. Y. Gong, S. Shi, P. W. Dong, B. Yang, X. R. Qi, G. Guo, Y. C. Gu, X. Zhao, Y. Q. Wei, and Z. Y. Qian, Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel: Part 1-Synthesis, characterization, and acute toxicity evaluation. J. Pharm. Sci. 98, 4684 (2009).
44. C. Y. Gong, S. Shi, L. Wu, M. L. Gou, Q. Q. Yin, Q. F. Guo, P. W. Dong, F. Zhang, F. Luo, X. Zhao, Y. Q. Wei, and Z. Y. Qian, Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: Sol-gel- sol transition and drug delivery behavior. Acta Biomater. 5, 3358 (2009).
45. C. Y. Gong, Q. J. Wu, P. W. Dong, S. Shi, S. Z. Fu, G. Guo, H. Z. Hu, X. Zhao, Y. Q. Wei, and Z. Y. Qian, Acute toxicity evaluation of biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PEG-PCL-PEG hydrogel. J. Biomed. Mater. Res. B 91, 26 (2009).
46. X. W. Wei, C. Y. Gong, M. Y. Gou, S. Z. Fu, Q. F. Guo, S. Shi, F. Luo, G. Guo, L. Y. Qiu, and Z. Y. Qian, Biodegradable poly(epsilon-caprolactone)- poly(ethylene glycol) copolymers as drug delivery system. Int. J. Pharm. 381, 1 (2009).
47. S. I. CelIkoglu, F. CelIkoglu, and E. P. Goldberg, Endobronchial intratumoral chemotherapy (EITC) followed by surgery in early non-small cell lung cancer with polypoid growth causing erroneous impression of advanced disease. Lung Cancer 54, 339 (2006).